top of page

Search


agbiopro
Aug 19, 20200 min read


agbiopro
Aug 19, 20200 min read


agbiopro
Aug 3, 20200 min read


agbiopro
Aug 3, 20200 min read


agbiopro
Jun 30, 20200 min read


agbiopro
Apr 29, 20200 min read


agbiopro
Jun 20, 20190 min read


agbiopro
Jun 18, 20190 min read


UK Immune Cell Therapy Biotech Founded with €40M Series A
Quell Therapeutics, a London-based biotech developing immune cell therapies to target transplant rejection and autoimmune and...
agbiopro
May 30, 20191 min read


agbiopro
May 18, 20190 min read


agbiopro
May 10, 20190 min read


agbiopro
May 2, 20190 min read


agbiopro
Apr 28, 20190 min read


agbiopro
Apr 23, 20190 min read


The top 20 preclinical biotech deals ranked by cash upfront reveals 3 big players — and some major l
agbiopro
Apr 23, 20190 min read


A 1.2 Bilion Gene Therapy Deal
Less than a month after Thermo Fisher unveiled a $1.7 billion deal to swallow Brammer Bio — a company that does contract viral vector...
agbiopro
Apr 21, 20191 min read


agbiopro
Apr 14, 20190 min read
bottom of page